Showing results (2311-2320 of 3,507) with videos related to
Sort By:
Pageof 351
Eclinicalmedicine|May 30, 2024
Diabetic and hypertensive disorders following early pregnancy loss: a systematic review and meta-analysisJennifer Dunne, Damien Foo, Berihun A Dachew, et al.Eclinicalmedicine|May 13, 2024
Once-weekly semaglutide versus placebo in adults with increased fracture risk: a randomised, double-blinded, two-centre, phase 2 trialMorten S Hansen, Eva M Wölfel, Shakespeare Jeromdesella, et al.Eclinicalmedicine|May 10, 2024
Psychological outcomes in patients with rare cancers: a systematic review and meta-analysisChen Ee Low, Sean Loke, Ga Eun Pang, et al.Eclinicalmedicine|May 15, 2024
Niraparib maintenance therapy using an individualised starting dose in patients with platinum-sensitive recurrent ovarian cancer (NORA): final overall survival analysis of a phase 3 randomised, placebo-controlled trialXiaohua Wu, Jianqing Zhu, Rutie Yin, et al.Eclinicalmedicine|May 6, 2024
Gestational diabetes mellitus and development of intergenerational non-alcoholic fatty liver disease (NAFLD) after delivery: a systematic review and meta-analysisRu Xun Foo, Jenny Junyi Ma, Ruochen Du, et al.Eclinicalmedicine|May 27, 2024
Global maternal mortality projections by urban/rural location and education level: a simulation-based analysisZachary J Ward, Rifat Atun, Gary King, et al.Eclinicalmedicine|May 17, 2024
Weight loss outcomes with semaglutide based on diabetes severity using the individualized metabolic surgery scoreWissam Ghusn, Diego Anazco, Sima Fansa, et al.Eclinicalmedicine|May 17, 2024
Efficacy and safety of sympathetic mapping and ablation of renal nerves for the treatment of hypertension (SMART): 6-month follow-up of a randomised, controlled trialJie Wang, Yuehui Yin, Chengzhi Lu, et al.Eclinicalmedicine|April 18, 2024
Sex and gender differences in hepatitis C virus risk, prevention, and cascade of care in people who inject drugs: systematic review and meta-analysisAnna Levinsson, Camille Zolopa, Farzaneh Vakili, et al.Eclinicalmedicine|April 15, 2024
Effectiveness of the Sanofi/GSK (VidPrevtyn Beta) and Pfizer-BioNTech (Comirnaty Original/Omicron BA.4-5) bivalent vaccines against hospitalisation in EnglandFreja Cordelia Møller Kirsebom, Nick Andrews, Julia Stowe, et al.Pageof 351